• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » BioSphere Medical narrows net loss

BioSphere Medical narrows net loss

July 30, 2009 By MassDevice staff

Customer outreach and other marketing efforts may be starting to pay off for Biosphere Medical Inc.

The Rockland, Mass.-based maker of microscopic polymer beads reported $8.1 million in sales during the three months ended June 30, with a 13 percent jump in U.S. sales of the company’s interventional gynecology products pacing much of that gain.

The net loss for the period was $677,000, which compares with a $1.3 million loss on $7.6 million in sales during the June 2008 quarter.

Biosphere CEO Richard Faleschini said the company’s use of community health talks, or CHTs, was working well to expand acceptance of embolotherapy as an appropriate tool to treat fibroids — benign but often painful tumors — in the uterus afflicting as many as one in four women over 45 years of age.

The CHTs began at five hospitals early this year and have since expanded to 13 U.S. cities, with over 1,700 women with symptomatic fibroids participating in the sit-down seminars with physicians and BioSphere sales reps. Those talks led about 550 women to seek individual consultations, with a “high percentage of those consults” leading to procedures using Biosphere embolics, Faleschini said.

Overall U.S. sales during the second quarter reached $6.7 million, which includes about $1.6 million in sales of embolics used in oncology treatments.

Faleschini also said the company is continuing to talk with U.S. regulators about criteria for a trial BioSphere hopes to start early next year of drug-eluting microspheres to treat liver cancer patients.

Filed Under: Business/Financial News, Gynecological

More recent news

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Apreo Health emerges from stealth with positive data for lung scaffold
  • Tivic adds new vagus nerve stim patent
  • Study backs Teleflex stapler for reducing post-op GERD rates

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy